Receptor location matters for psychedelic drug effects
- Details
- Category: Research
Location, location, location is the key for psychedelic drugs that could treat mental illness by rapidly rebuilding connections between nerve cells. In a paper published Feb. 17 in Science, researchers at the University of California, Davis show that engaging serotonin 2A receptors inside neurons promotes growth of new connections but engaging the same receptor on the surface of nerve cells does not.
Paxlovid substantially reduced risk of hospitalization, death during Omicron wave
- Details
- Category: Research
Nirmatrelvir-ritonavir (Paxlovid) significantly reduced the likelihood of hospitalization or death from COVID-19 in people at risk of severe illness, according to new research in CMAJ (Canadian Medical Association Journal).
The study, conducted by Ontario researchers, aimed to evaluate the effectiveness of nirmatrelvir–ritonavir in preventing severe illness during the emergence of the Omicron variant.
CAR-T cell cancer immunotherapy gets personal
- Details
- Category: Research
New adoptive T cell therapies - in which T cells, the immune system's natural hunters patrolling the body for foreign adversaries, are retrieved from cancer-riddled patients, super-charged and amplified outside the body, and then infused back into the same patient - are changing the prospects of cancer patients.
Researchers discover causal mechanism behind rare hereditary diseases
- Details
- Category: Research
Researchers from Charité - Universitätsmedizin Berlin, the Max Planck Institute for Molecular Genetics (MPIMG), and the University Hospital Schleswig-Holstein (UKSH) have investigated in detail how BPTA syndrome, an extremely rare hereditary condition, arises. A change in the charge of a protein disrupts cellular self-organization, resulting in a developmental disorder.
Scientists pinpoint protein that helps cancer-causing viruses evade immune response
- Details
- Category: Research
The viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) have been linked to several cancers. For the first time, UNC School of Medicine scientists have discovered that these viruses use a human protein called barrier-to-autointegration factor 1, or BAF, to evade our innate immune response, allowing the viruses to spread and cause disease.
Transforming the way cancer vaccines are designed and made
- Details
- Category: Research
A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University. The scientists used chemistry and nanotechnology to change the structural location of adjuvants and antigens on and within a nanoscale vaccine, greatly increasing vaccine performance.
Antidepressants used for chronic pain on the rise, but are they effective?
- Details
- Category: Research
New research has found some antidepressants may be effective in treating certain chronic pain conditions, but others lack convincing evidence on their effectiveness.
Many people are unaware that some antidepressants (medications used to treat people living with depression) are also being prescribed to treat certain chronic pain conditions.
More Pharma News ...
- Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
- Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
- Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
- Power of cancer drugs may see boost by targeting newly ID'd pathway
- A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
- 500,000 missed out on blood pressure lowering drugs during pandemic
- Modified CRISPR-based enzymes improve the prospect of inserting entire genes into the genome to overcome diverse disease-causing mutations